Statistics for Rani Therapeutics Holdings, (id:6601 RANI)

Valuation metrics

Market cap

121.78M

Enterprise value

75.89M

Trailing P/E (ttm)

-1.56

Forward P/E

-2.06

PEG ratio

-2.06

Price/Sales (ttm)

Price/Book (mrq)

4.21

Enterprise Value/Revenue

Enterprise Value/EBITDA

-1.33

Overview

Shares outstanding

33.31M

Float

20.43M

Shares short

1.49M

% Held by insiders

0.31%

% Held by institutions

0.20%

Average volume (10 days)

530.68K

Average volume (90 days)

Price summary

52-Week low

1.90

52-Week high

8.75

52-Week change

4.81%

Beta

0.11

50-Day moving average

2.34

200-Day moving average

3.60

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

0.00%

Operational effectiveness

Return on assets

-56.83%

Return on equity

-225.35%

Income statement

Revenue (ttm)

0.00

Revenue per share (ttm)

0.00

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-56,898,000.00

Net income to common (ttm)

-30,583,000.00

Diluted EPS (ttm)

-1.05

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

30.90M

Total cash per share (mrq)

1.06

Total debt (mrq)

35.25M

Total Debt/Equity (mrq)

635.10

Current ratio (mrq)

193.20%

Book value per share (mrq)

0.49

Cash flow

Cash flow statement

-45,212,000.00

Levered free cash flow (LFCF)

-22,836,124.00